Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial – The Lancet Infectious Diseases News Release: Study shows metformin lowers the risk of getting long COVID – University of Minnesota Medical School Commentary: Expert reaction to study on Metformin after testing positive for […]

The post 2ry Analysis of a RCT | Metformin linked to 41% reduction in long COVID incidence in outpatient treatment appeared first on Links Medicus.